Hedvat CV - Search Results

1

Akt phosphorylates the transcriptional repressor bmi1 to block its effects on the tumor-suppressing ink4a-arf locus.

Liu Y, Liu F, Yu H, Zhao X, Sashida G, Deblasio A, Harr M, She QB, Chen Z, Lin HK, Di Giandomenico S, Elf SE, Yang Y, Miyata Y, Huang G, Menendez S, Mellinghoff IK, Rosen N, Pandolfi PP, Hedvat CV, Nimer SD. Liu Y, et al. Among authors: hedvat cv. Sci Signal. 2012 Oct 23;5(247):ra77. doi: 10.1126/scisignal.2003199. Sci Signal. 2012. PMID: 23092893 Free PMC article.

2

The ETS protein MEF plays a critical role in perforin gene expression and the development of natural killer and NK-T cells.

Lacorazza HD, Miyazaki Y, Di Cristofano A, Deblasio A, Hedvat C, Zhang J, Cordon-Cardo C, Mao S, Pandolfi PP, Nimer SD. Lacorazza HD, et al. Immunity. 2002 Oct;17(4):437-49. doi: 10.1016/s1074-7613(02)00422-3. Immunity. 2002. PMID: 12387738 Free article.

3

Tumor promoting properties of the ETS protein MEF in ovarian cancer.

Yao JJ, Liu Y, Lacorazza HD, Soslow RA, Scandura JM, Nimer SD, Hedvat CV. Yao JJ, et al. Among authors: hedvat cv. Oncogene. 2007 Jun 7;26(27):4032-7. doi: 10.1038/sj.onc.1210170. Epub 2007 Jan 8. Oncogene. 2007. PMID: 17213815

4

The ETS protein MEF is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2.

Liu Y, Hedvat CV, Mao S, Zhu XH, Yao J, Nguyen H, Koff A, Nimer SD. Liu Y, et al. Among authors: hedvat cv. Mol Cell Biol. 2006 Apr;26(8):3114-23. doi: 10.1128/MCB.26.8.3114-3123.2006. Mol Cell Biol. 2006. PMID: 16581786 Free PMC article.

5

Myeloid ELF1-like factor is a potent activator of interleukin-8 expression in hematopoietic cells.

Hedvat CV, Yao J, Sokolic RA, Nimer SD. Hedvat CV, et al. J Biol Chem. 2004 Feb 20;279(8):6395-400. doi: 10.1074/jbc.M307524200. Epub 2003 Nov 17. J Biol Chem. 2004. PMID: 14625302 Free article.

6

Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma.

Hedvat CV, Hegde A, Chaganti RS, Chen B, Qin J, Filippa DA, Nimer SD, Teruya-Feldstein J. Hedvat CV, et al. Hum Pathol. 2002 Oct;33(10):968-74. doi: 10.1053/hupa.2002.127438. Hum Pathol. 2002. PMID: 12395368

7

Insights into extramedullary tumour cell growth revealed by expression profiling of human plasmacytomas and multiple myeloma.

Hedvat CV, Comenzo RL, Teruya-Feldstein J, Olshen AB, Ely SA, Osman K, Zhang Y, Kalakonda N, Nimer SD. Hedvat CV, et al. Br J Haematol. 2003 Sep;122(5):728-44. doi: 10.1046/j.1365-2141.2003.04481.x. Br J Haematol. 2003. PMID: 12930383 Free article.

8

Molecular biology of leukemia.

Jakubowiak A, Cammenga J, Sokolic R, Alvarez S, Jackson G, Hedvat C, Nimer SD. Jakubowiak A, et al. Curr Oncol Rep. 2000 Mar;2(2):123-31. doi: 10.1007/s11912-000-0083-z. Curr Oncol Rep. 2000. PMID: 11122833 Review.

9

Macrophage-derived chemokine expression in classical Hodgkin's lymphoma: application of tissue microarrays.

Hedvat CV, Jaffe ES, Qin J, Filippa DA, Cordon-Cardo C, Tosato G, Nimer SD, Teruya-Feldstein J. Hedvat CV, et al. Mod Pathol. 2001 Dec;14(12):1270-6. doi: 10.1038/modpathol.3880473. Mod Pathol. 2001. PMID: 11743050

10

Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma.

Hassoun H, Reich L, Klimek VM, Dhodapkar M, Cohen A, Kewalramani T, Zimman R, Drake L, Riedel ER, Hedvat CV, Teruya-Feldstein J, Filippa DA, Fleisher M, Nimer SD, Comenzo RL. Hassoun H, et al. Among authors: hedvat cv. Br J Haematol. 2006 Jan;132(2):155-61. doi: 10.1111/j.1365-2141.2005.05848.x. Br J Haematol. 2006. PMID: 16398649 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

65 results

Search Page

Filters